Ken Griffin Night Hawk Biosciences, Inc. Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.51 $4,059 - $7,962	15,612 Added 508.7%	18,681 $8,000
Q3 2023 Nov 14, 2023	BUY	$0.5 - $0.72 $1,534 - $2,209	3,069 New	3,069 $1,000
Q1 2023 May 15, 2023	SELL	$0.83 - $1.24 $26,687 - $39,870	-32,154 Reduced 40.82%	46,620 $40,000
Q4 2022 Feb 14, 2023	BUY	$0.77 - $1.62 $24,030 - $50,556	31,208 Added 65.61%	78,774 $63,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $64,368 - $106,441	-35,960 Reduced 43.05%	47,566 $82,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.